Genetic alterations of human brain tumors as molecular prognostic factors.
Despite a number of basic and clinical studies, it is still very difficult to improve the prognosis of patients with high-grade astrocytoma. However, the recent success of procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea and vincristine (PCV) chemotherapy for oligodendrogliomas that have lost chromosomes 1p and 19q has encouraged the authors to evaluate the biological behavior of brain tumors by means of genetic analysis. Both the disorders of the p53/MDM2/p14(ARF) and the p16(INK4a)/RB signaling pathways have been found to play an essential role in tumorigenesis of various brain tumors. Herein, the authors summarize the genetic alterations of brain tumors by mainly focusing on two pathways that appear to affect significantly the patient prognosis.
Shiraishi
Tetsuya
T
Department of Neurosurgery, Saga Medical School, Saga, Japan. shiraish@post.saga-med.ac.jp
Tabuchi
Kazuo
K
D014408:Biomarkers, Tumor / Q000235:genetics*; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000235:genetics*; D004273:DNA, Neoplasm / Q000235:genetics*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D011237:Predictive Value of Tests; D011379:Prognosis; D015398:Signal Transduction / Q000235:genetics
D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm